|
Session 156
Poster Abstracts
Integrase Inhibitor Therapy in Children
Monday, 1-2:30 pm
Poster Hall |
873
 |
Raltegravir In Children and Adolescents: The French Expanded Access Program
Isabelle Thuret*1, C Tamalet2, V Reliquet3, G Firtion4, P Frange5, J Tricoire6, H Aumaitre7, C Rabaud8, M-L Chaix5, and S Blanche9
1Hématologie Pédiatrique APHM, Marseille, France; 2Laboratoire de Virologie, APHM, Marseille, France; 3Hématologie Pédiatrique CHU Nantes, France; 4Service d`Infectiologie, CHU Cochin, APHP, Paris, France; 5Laboratoire de Virologie, Hôpital Necker, APHP, France; 6Pédiatrie, CHU Toulouse, France; 7Service de gastro-entérologie, CH Perpignan, france; 8Infectiologie, CHU Nancy, France; and 9Hématologie Pédiatrique Hôpital Necker, APHP, Paris France |
874
|
Safety and Efficacy of Raltegravir in Pediatric HIV Infection. Preliminary Analysis from the International Maternal Pediatric Adolescent AIDS Clinical Trials Group, P1066
Andrew Wiznia*1, P Samson2, E Acosta3, H Teppler4, E Sheeran5, B Graham6, T Fenton2, E Handelsman7, C Worrell8, S Nachman9, and IMPAACT P1066
1Jacobi Med Ctr, Albert Einstein Coll of Med, Bronx, NY, US; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3Univ of Alabama at Birmingham, US; 4Merck Res Labs, North Wales, PA, US; 5Social & Sci Systems Inc, Silver Spring, MD, US; 6Frontier Sci & Tech Res Fndn, Amherst, NY, US; 7NIAID, NIH, Bethesda, MD, US; 8Natl Inst of Child Hlth and Human Devt, NIH, Bethesda, MD, US; and 9State Univ of New York at Stony Brook, US |
|
